Suppr
超能文献

Development of RISS in two patients with NMOSD undergoing rituximab treatment: a case report.

作者信息

Ersöz Ayça Simay, Yaşargün Duygu Özkan, Mısırlı Cemile Handan

机构信息

Department of Neurology, University of Health Sciences Türkiye, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.

出版信息

Acta Neurol Belg. 2024 Jun;124(3):1041-1042. doi: 10.1007/s13760-023-02412-w. Epub 2023 Oct 30.

DOI:10.1007/s13760-023-02412-w

PMID:37904077

Abstract

摘要

相似文献

Development of RISS in two patients with NMOSD undergoing rituximab treatment: a case report.

Acta Neurol Belg. 2024 Jun;124(3):1041-1042. doi: 10.1007/s13760-023-02412-w. Epub 2023 Oct 30.

Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.

Mult Scler Relat Disord. 2018 Feb;20:192-193. doi: 10.1016/j.msard.2018.01.006. Epub 2018 Mar 20.

Advances in the Treatment of Neuromyelitis Optica Spectrum Disorder.

Neurol Clin. 2021 Feb;39(1):35-49. doi: 10.1016/j.ncl.2020.09.003. Epub 2020 Nov 7.

Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.

J Neurol Sci. 2017 Jan 15;372:92-96. doi: 10.1016/j.jns.2016.11.016. Epub 2016 Nov 10.

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.

Lancet Neurol. 2020 Apr;19(4):298-306. doi: 10.1016/S1474-4422(20)30066-1. Epub 2020 Mar 18.

Low-dosage of rituximab in Chinese patients with neuromyelitis optica spectrum disorder.

J Neuroimmunol. 2018 Apr 15;317:1-4. doi: 10.1016/j.jneuroim.2018.02.004. Epub 2018 Feb 6.

Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial.

J Neurol. 2017 Sep;264(9):2003-2009. doi: 10.1007/s00415-017-8590-0. Epub 2017 Aug 22.

Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.

Mult Scler Relat Disord. 2020 Sep;44:102245. doi: 10.1016/j.msard.2020.102245. Epub 2020 Jun 1.

Hiccups as Herald: Neuromyelitis Optica Spectrum Disorder.

Am J Med. 2017 Sep;130(9):1055-1058. doi: 10.1016/j.amjmed.2017.05.005. Epub 2017 Jun 24.

Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica: Influence of FCGR3A Polymorphisms on the Therapeutic Response to Rituximab.

JAMA Neurol. 2015 Sep;72(9):989-95. doi: 10.1001/jamaneurol.2015.1276.

本文引用的文献

Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study.

Eur J Intern Med. 2019 Sep;67:59-64. doi: 10.1016/j.ejim.2019.06.009. Epub 2019 Jul 3.

Individualized B cell-targeting therapy for neuromyelitis optica spectrum disorder.

Neurochem Int. 2019 Nov;130:104347. doi: 10.1016/j.neuint.2018.11.022. Epub 2018 Dec 1.

Rituximab-induced serum sickness in refractory immune thrombocytopenic purpura.

Intern Med J. 2011 Feb;41(2):202-5. doi: 10.1111/j.1445-5994.2010.02384.x.

Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab).

Arthritis Rheum. 2001 Jul;44(7):1717-8. doi: 10.1002/1529-0131(200107)44:7<1717::AID-ART299>3.0.CO;2-C.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Development of RISS in two patients with NMOSD undergoing rituximab treatment: a case report.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译